Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans? / Asmar, Meena; Bache, Michael; Knop, Filip K; Madsbad, Sten; Holst, Jens Juul.

In: The Journal of clinical endocrinology and metabolism, Vol. 95, No. 5, 01.05.2010, p. 2367-75.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Asmar, M, Bache, M, Knop, FK, Madsbad, S & Holst, JJ 2010, 'Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?', The Journal of clinical endocrinology and metabolism, vol. 95, no. 5, pp. 2367-75. https://doi.org/10.1210/jc.2009-2133

APA

Asmar, M., Bache, M., Knop, F. K., Madsbad, S., & Holst, J. J. (2010). Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans? The Journal of clinical endocrinology and metabolism, 95(5), 2367-75. https://doi.org/10.1210/jc.2009-2133

Vancouver

Asmar M, Bache M, Knop FK, Madsbad S, Holst JJ. Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans? The Journal of clinical endocrinology and metabolism. 2010 May 1;95(5):2367-75. https://doi.org/10.1210/jc.2009-2133

Author

Asmar, Meena ; Bache, Michael ; Knop, Filip K ; Madsbad, Sten ; Holst, Jens Juul. / Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?. In: The Journal of clinical endocrinology and metabolism. 2010 ; Vol. 95, No. 5. pp. 2367-75.

Bibtex

@article{b063b01935b2414b935386f450b46825,
title = "Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?",
abstract = "Amylin, cosecreted with insulin, has like glucagon-like peptide-1 (GLP-1) been reported to inhibit glucagon secretion, delay gastric emptying, and reduce appetite and food intake. We investigated whether the effects of GLP-1 on gastric emptying, appetite, and food intake are mediated directly or indirectly via release of amylin.",
keywords = "Adult, Amyloid, Appetite, Body Mass Index, C-Peptide, Cross-Over Studies, Diabetes Mellitus, Type 1, Gastric Emptying, Glucagon, Glucagon-Like Peptide 1, Hemoglobin A, Glycosylated, Humans, Hypoglycemic Agents, Insulin, Islet Amyloid Polypeptide, Reference Values, Single-Blind Method",
author = "Meena Asmar and Michael Bache and Knop, {Filip K} and Sten Madsbad and Holst, {Jens Juul}",
year = "2010",
month = may,
day = "1",
doi = "10.1210/jc.2009-2133",
language = "English",
volume = "95",
pages = "2367--75",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

AU - Asmar, Meena

AU - Bache, Michael

AU - Knop, Filip K

AU - Madsbad, Sten

AU - Holst, Jens Juul

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Amylin, cosecreted with insulin, has like glucagon-like peptide-1 (GLP-1) been reported to inhibit glucagon secretion, delay gastric emptying, and reduce appetite and food intake. We investigated whether the effects of GLP-1 on gastric emptying, appetite, and food intake are mediated directly or indirectly via release of amylin.

AB - Amylin, cosecreted with insulin, has like glucagon-like peptide-1 (GLP-1) been reported to inhibit glucagon secretion, delay gastric emptying, and reduce appetite and food intake. We investigated whether the effects of GLP-1 on gastric emptying, appetite, and food intake are mediated directly or indirectly via release of amylin.

KW - Adult

KW - Amyloid

KW - Appetite

KW - Body Mass Index

KW - C-Peptide

KW - Cross-Over Studies

KW - Diabetes Mellitus, Type 1

KW - Gastric Emptying

KW - Glucagon

KW - Glucagon-Like Peptide 1

KW - Hemoglobin A, Glycosylated

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Islet Amyloid Polypeptide

KW - Reference Values

KW - Single-Blind Method

U2 - 10.1210/jc.2009-2133

DO - 10.1210/jc.2009-2133

M3 - Journal article

C2 - 20194711

VL - 95

SP - 2367

EP - 2375

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -

ID: 33940040